This is a 2022 GSK trial. Same class as Keytuda and Opdivo

All Hokie, All the Time. Period. Presented by

The Lounge

Post #1620972 ◀ PREV NEXT ▶

Joined: 10/13/2005

Posts: 2,477

Likes: 2,198

Va AandM

It’s approved for endometrial cancer

Posted: 04/05/2024 at 12:35 PM ET

(In response to this post by Late 80s Hokie)

100% Cancer Remission Achieved in ALL Patients in Groundbreaking Study -- EDGEMAN Apr 05, 2024 at 11:00 AM ET

EDGEMAN • 04/05/24 11:00 AM ET

Good thing that this didn't come out on April 1st. -- MikeVT85 Apr 05, 2024 at 04:57 PM ET

MikeVT85 • 04/05/24 04:57 PM ET

WOW is right. Wonder the viability on other cancers?** -- HOKIERIT Apr 05, 2024 at 03:33 PM ET

HOKIERIT • 04/05/24 03:33 PM ET

Small study as you said but still impressive -- No Clue Apr 05, 2024 at 02:29 PM ET

No Clue • 04/05/24 02:29 PM ET

Would be nice, but Vigilant News? A little sus.** -- KfgsHokie Apr 05, 2024 at 02:23 PM ET

KfgsHokie • 04/05/24 02:23 PM ET

Remember, remission is limited by time frame. -- VToncologyNurse Apr 05, 2024 at 01:50 PM ET

VToncologyNurse • 04/05/24 01:50 PM ET

Is this a treatment where it kick starts the body's own immune response... -- EDGEMAN Apr 05, 2024 at 02:24 PM ET

EDGEMAN • 04/05/24 02:24 PM ET

Yes. It only works on a very small % of tumors where they have an MMR -- VTENGR Apr 05, 2024 at 03:05 PM ET

VTENGR • 04/05/24 03:05 PM ET

So which company has THE most successful cancer treatment drug? Expect -- Late 80s Hokie Apr 05, 2024 at 12:26 PM ET

Late 80s Hokie • 04/05/24 12:26 PM ET

This is a 2022 GSK trial. Same class as Keytuda and Opdivo ◄ -- Va AandM Apr 05, 2024 at 12:35 PM ET

Va AandM • 04/05/24 12:35 PM ET

Chris Rock..."They don't cure sh*t...the money is in the medicine"** -- Tuckahokie Apr 05, 2024 at 12:28 PM ET

Tuckahokie • 04/05/24 12:28 PM ET